The impact of epigenetic chemical probes: expanding targeting modalities and disease understanding

Small-molecule chemical modulators (chemical probes) targeting epigenetic regulators are essential tools for research by enabling precise temporal control over chromatin dynamics. Over the past two decades, large international efforts have produced hundreds of validated and openly accessible chemical probes. While the field was initially driven by occupancy-based catalytic inhibitors, there has been a recent shift toward context-dependent target engagement and induced proximity strategies. By repurposing established chemical ligands, next-generation heterobifunctional modalities (e.g., PROTACs and RIPTACs) can drive targeted protein degradation or disrupt multi-protein complexes to achieve deeper functional effects. In the present review, we discuss the evolution of epigenetic chemical probes, the emergence of induced proximity strategies, and the importance of recognizing that different targeting modalities for a given protein may yield distinct biological outcomes. Collectively, the history of epigenetic probes provides a foundation for Target 2035, an international initiative led by the Structural Genomics Consortium aimed at developing pharmacological modulators across the human proteome.

Authors

Institutions

Publication Details

Journal
Essays in Biochemistry
Published
2026-11-18
DOI
https://doi.org/10.1042/ebc20260009
Primary Topic
Protein Degradation and Inhibitors
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The impact of epigenetic chemical probes: expanding targeting modalities and disease understanding

C.H. Arrowsmith, Dalia Baršytė-Lovejoy, Philip Barbulescu
1 links
Essays in Biochemistry
Protein Degradation and Inhibitors
article

The impact of epigenetic chemical probes: expanding targeting modalities and disease understanding

C.H. Arrowsmith, Dalia Baršytė-Lovejoy, Philip Barbulescu
article en

Abstract

Small-molecule chemical modulators (chemical probes) targeting epigenetic regulators are essential tools for research by enabling precise temporal control over chromatin dynamics. Over the past two decades, large international efforts have produced hundreds of validated and openly accessible chemical probes. While the field was initially driven by occupancy-based catalytic inhibitors, there has been a recent shift toward context-dependent target engagement and induced proximity strategies. By repurposing established chemical ligands, next-generation heterobifunctional modalities (e.g., PROTACs and RIPTACs) can drive targeted protein degradation or disrupt multi-protein complexes to achieve deeper functional effects. In the present review, we discuss the evolution of epigenetic chemical probes, the emergence of induced proximity strategies, and the importance of recognizing that different targeting modalities for a given protein may yield distinct biological outcomes. Collectively, the history of epigenetic probes provides a foundation for Target 2035, an international initiative led by the Structural Genomics Consortium aimed at developing pharmacological modulators across the human proteome.

Essays in Biochemistry
University Health Network (CA), University of Toronto (CA), Princess Margaret Cancer Centre (CA), Structural Genomics Consortium (CA)
Good health and well-being
Protein Degradation and Inhibitors
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon